New Delhi: Biotechnology firm Biocon’s custom research arm Syngene has appointed Peter Bains as its chief executive officer (CEO).

“Company’s Subsidiary Syngene International (Syngene) has appointed Peter Bains, director, as the CEO of Syngene," Biocon said in a filing to BSE.

Bains has been a director of Syngene, since 2011. Syngene had on Tuesday said it would set up a new plant at Mangalore SEZ (special economic zone) to manufacture pharma ingredients and agro chemicals and is in the process of acquiring approximately 40 acres of land in the SEZ.

There has been speculation that Biocon would file a prospectus for listing Syngene soon. Biocon had sold its 10% stake in Syngene for 380 crore to IVF Trustee Co. Pvt. Ltd. The deal had put the entire valuation of Syngene International Ltd at 3,800 crore.

Close